Ian M. Catlett
- Immunology top 5%
- Psoriasis: Treatment and Pathogenesis 7
- Rheumatology top 5%
- Systemic Lupus Erythematosus Research 8
- Rheumatoid Arthritis Research and Therapies 3
- Hepatology top 10%
- Oncology top 10%
- Cytokine Signaling Pathways and Interactions 19
- HER2/EGFR in Cancer Research 3
-
- Monoclonal and Polyclonal Antibodies Research 7
-
- Chronic Lymphocytic Leukemia Research 5
-
- Synthesis and biological activity 2
- Co-authors
- Gail A. BishopBruce S. HostagerIhab GirgisDennis M. GraselaSubhashis BanerjeeScott C. BrakenridgeCraig M. CoopersmithRichard S. Hotchkiss
- Cited by
- ImmunologyRheumatologyHepatology
- Journals
- Annals of the Rheumatic Diseases (8 papers)The Journal of Immunology (2 papers)Dermatology and Therapy (2 papers)
- Partner nations
- United StatesAustraliaNetherlands
In The Last Decade
Ian M. Catlett
32 papers receiving 1.1k citations
Hit Papers
Peers
Comparison fields: 5 of 79
- Immunology 632
- Rheumatology 214
- Hepatology 108
- Critical Care and Intensive Care Medicine 65
- Oncology 304
Countries citing papers authored by Ian M. Catlett
This map shows the geographic impact of Ian M. Catlett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian M. Catlett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian M. Catlett more than expected).
Fields of papers citing papers by Ian M. Catlett
This network shows the impact of papers produced by Ian M. Catlett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian M. Catlett. The network helps show where Ian M. Catlett may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ian M. Catlett, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 6 | |
| 4 | 2024 | 2 | |
| 5 | 2023 | 3 | |
| 6 | 2023 | 1 | |
| 7 | 2023 | 6 | |
| 8 | 2023 | 1 | |
| 9 | Deucravacitinib, a Tyrosine Kinase 2 Inhibitor, in Systemic Lupus Erythematosus: A Phase | 2022 | 139 |
| 10 | 2021 | 51 | |
| 11 | 2021 | 88 | |
| 12 | 2019 | 136 | |
| 13 | 2019 | 167 | |
| 14 | 2019 | 9 | |
| 15 | 2017 | 26 | |
| 16 | 2011 | 7 | |
| 17 | 2005 | 35 | |
| 18 | 2001 | 30 | |
| 19 | 2000 | 171 | |
| 20 | 1999 | 35 |
About Ian M. Catlett
Ian M. Catlett is a scholar working on Oncology, Rheumatology and Genetics, having authored 33 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cytokine Signaling Pathways and Interactions (19 papers), Systemic Lupus Erythematosus Research (8 papers), Psoriasis: Treatment and Pathogenesis (7 papers), Monoclonal and Polyclonal Antibodies Research (7 papers), Chronic Lymphocytic Leukemia Research (5 papers), HER2/EGFR in Cancer Research (3 papers), Rheumatoid Arthritis Research and Therapies (3 papers) and Synthesis and biological activity (2 papers). The work is most often cited by research in Immunology (632 citations), Rheumatology (214 citations) and Hepatology (108 citations). Ian M. Catlett has collaborated with scholars based in United States, Australia and Netherlands. Frequent co-authors include Gail A. Bishop, Bruce S. Hostager, Ihab Girgis, Dennis M. Grasela, Subhashis Banerjee, Scott C. Brakenridge, Craig M. Coopersmith, Richard S. Hotchkiss, Lyle L. Moldawer and Florian Mayr. Their work appears in journals such as Annals of the Rheumatic Diseases, The Journal of Immunology, Dermatology and Therapy, Critical Care Medicine and Arthritis & Rheumatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.